Navigation Links
NIH Clinical and Translational Science Consortium grows to 39 members

The National Institutes of Health announced today that the University of Cincinnati will become the 39th member of its Clinical and Translational Science Award (CTSA) consortium. Led by the National Center for Research Resources (NCRR), part of the NIH, this national network of medical research institutions is working together to accelerate the process of turning laboratory discoveries into treatments for patients, to engage communities in clinical research efforts and to train the next generation of clinical and translational researchers.

The consortium was launched in 2006, with new members added in 2007 and 2008. Approximately 60 CTSAs will be connected when the program is fully implemented in 2012. NCRR will award additional CTSA grants this year; more awards are expected in the next several months.

In this latest award, the University of Cincinnati will receive $22.7 million over five years. The new Center for Clinical and Translational Science and Training will expand its support for pediatric research through the Cincinnati Children's Hospital Medical Center; enhance new translational technologies, including large-scale studies of proteins (proteomics), drug discovery, imaging, nanomedicine, gene transfer and stem cell biology. The center also will increase outreach into the local community, including collaborations with the Cincinnati Veterans Affairs Medical Center. Additional information about the grant can be found at

"Among the many strengths of this newest CTSA consortium member is the depth of pediatric research conducted at the Cincinnati Children's Hospital one of the top pediatric research hospitals in the nation," said NCRR Director Barbara Alving, M.D. "As part of this national clinical and translational research network, the University of Cincinnati will focus on both pediatric and adult diseases and will increase the breadth of consortium activity throughout the Midwest, bringing research advances into the communities it serves."

Since its launch in 2006, the consortium has been:

  • training researchers in the complexities of clinical and translational research through nationally recognized degree-granting programs;
  • leveraging CTSA resources to expand research and training opportunities in underserved states and communities;
  • assembling interdisciplinary teams that include but are not limited to basic scientists, biologists, clinical researchers, dentists, veterinarians, nurses, pharmacists, biomedical engineers and geneticists;
  • partnering with researchers at minority institutions to enhance outreach to underserved populations, local community and advocacy organizations, and health care providers;
  • creating best practices to improve clinical research informatics tools to analyze research data and manage clinical trials;
  • designating technologies for marketing and licensing purposes that will increase global access to research tools; and
  • forging new partnerships with private and public health care organizations, including pharmaceutical companies, Departments of Veterans Affairs hospitals, and health maintenance organizations, as well as state health agencies.


Contact: NCRR Office of Communications
NIH/National Center for Research Resources

Related biology news :

1. U of M begins nations first clinical trial using T-reg cells from cord blood in leukemia treatment
2. Clinical studies show REMICADE reduces incidence of bowel surgeries in ulcerative colitis patients
3. Phase 2 of Singapores Biomedical Sciences Initiative gains momentum for clinical research
4. Cleveland Clinic leading clinical program to improve early-stage lung cancer detection
5. Singulex Teams With Wyeth Pharmaceuticals to Translate Pre-Clinical Biomarker Research Into Clinical Study Design
6. Study of African traditional medicine will begin world-first clinical trial
7. New clinical data shows chromium picolinate improves cognitive function
8. New clinical trial results show how personalized medicine will alter treatment of genetic disorders
9. Nucleonics initiates hepatitis B clinical trial with expressed interfering RNA therapeutic
10. Simple screening questionnaire for kidney disease outperforms current clinical practice guidelines
11. NHLBI issues first US von Willebrand Disease clinical practice guidelines
Post Your Comments:
(Date:11/11/2015)...   MedNet Solutions , an innovative SaaS-based eClinical technology ... pleased to announce that it will be a Sponsor of ... to be held November 17-19 in Hamburg ... of iMedNet , MedNet,s easy-to-use, proven and ... has been able to deliver time and cost savings of ...
(Date:11/4/2015)... New York , November 4, 2015 ... to a new market report published by Transparency Market ... Share, Growth, Trends and Forecast 2015 - 2022", the global ... of US$ 30.3 bn by 2022. The market is ... the forecast period from 2015 to 2022. Rising security ...
(Date:10/29/2015)... ARBOR, Mich. , Oct. 29, 2015 /PRNewswire/ ... Eurofins Genomics for U.S. distribution of its DNA ... DNA-seq kit and Rubicon,s new ThruPLEX Plasma-seq kit. ... to enable the preparation of NGS libraries for ... plasma for diagnostic and prognostic applications in cancer ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... , November 26, 2015 ... Global Biobanking Market 2016 - 2020 report analyzes ... maintaining integrity and quality in long-term samples, minimizing ... long-term cost-effectiveness. Automation minimizes manual errors such as ... technical efficiency. Further, it plays a vital role ...
(Date:11/25/2015)... BRUSSELS , November 25, 2015 ... in cat and human plaque and pave the way for ... health problems in cats     ... the most commonly diagnosed health problems in cats, yet relatively ... until now. Two collaborative studies have been conducted by researchers ...
(Date:11/25/2015)... /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS; TSX: AEZ) ... remain fundamentally strong and highlights the following developments: ... DSMB recommendation to continue the ZoptEC Phase 3 ... final interim efficacy and safety data , ... with heavily pretreated castration- and Taxane-resistant prostate cancer ...
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
Breaking Biology Technology: